Arterial calcification is the buildup of calcium-phosphate mineral deposits in artery walls, and it develops through an active, cell-driven process rather than the passive “rusting of the pipes” it was once assumed to be. The condition takes different forms depending on where in the artery wall the deposits settle, and its consequences range from stiffened blood vessels and high blood pressure to heart attacks and limb amputations. Understanding the causes, risks, and available treatments requires recognizing that not all arterial calcification is the same, and that some widely used medications can make it worse.
Two Distinct Types of Arterial Calcification
Calcium deposits can form in two separate layers of the artery wall, and the distinction matters because the causes, the diseases they associate with, and the clinical consequences differ. Intimal calcification develops in the inner lining of the artery, within atherosclerotic plaques. It occurs alongside the fatty deposits, immune cells, and cholesterol buildup that characterize plaque disease.1PubMed. Biology of calcification in vascular cells: intima versus media Medial calcification, sometimes called Mönckeberg-type calcification, forms in the muscular middle layer of the artery and can exist independently of atherosclerosis entirely.2Clinical Journal of the American Society of Nephrology. Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease
The two types also favor different vessels. Intimal calcification tends to show up in large elastic arteries like the aorta and the coronary arteries. Medial calcification is more common in smaller muscular arteries, including those in the legs and feet. Many patients, particularly those with chronic kidney disease or diabetes, develop both types simultaneously, which complicates diagnosis and treatment. Because the modifying agents differ at each site (lipids drive intimal deposits while elastin fibers anchor medial ones), the biological triggers are not interchangeable, even though both end up producing the same mineral: hydroxyapatite.
How Artery Cells Turn Into Bone
The old view of arterial calcification was that calcium simply precipitated out of the blood and stuck to damaged tissue, the way limescite builds up inside plumbing. Research over the past two decades has overturned that idea. Calcification is now recognized as a regulated, cell-driven process in which vascular smooth muscle cells, the cells that normally contract to control blood flow, transform into cells that resemble the osteoblasts found in bone.3PubMed Central. Mechanisms of the Osteogenic Switch of Smooth Muscle Cells in Vascular Calcification: WNT Signaling, BMPs, Mechanotransduction, and EndMT Risk factors like high blood pressure accelerate this transformation: smooth muscle cells lose their contractile identity and begin expressing bone-forming genes instead.4PubMed. Osteogenic transdifferentiation of vascular smooth muscle cells isolated from spontaneously hypertensive rats and potential menaquinone-4 inhibiting effect
Adding to this process, cells under stress release tiny membrane-bound packages called extracellular vesicles. These vesicles cluster between collagen fibers in the vessel wall and serve as seeds for mineral crystal growth, essentially acting as nucleation sites where calcium and phosphate latch on and accumulate.5PubMed Central. Role of Extracellular Vesicles in the Pathogenesis of Vascular Damage Under healthy conditions the body holds this process in check with natural inhibitors. One of the most important is Matrix Gla protein, or MGP, which blocks mineral formation in soft tissues. MGP depends on vitamin K to become activated. When MGP is deficient or inactive, calcification accelerates.6PubMed. Novel insights into uremic vascular calcification: role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuin
Why Kidney Disease Is the Biggest Accelerator
Chronic kidney disease stands out as the single strongest driver of arterial calcification. As kidney function declines, the body loses its ability to maintain a normal balance of calcium and phosphate. Phosphate accumulates in the blood and directly pushes smooth muscle cells toward their bone-like state, while elevated calcium triggers cell death and vesicle release. These two effects work together: when both calcium and phosphate are high, the combined stimulus is far greater than either one alone.7PubMed Central. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate
Beyond the mineral imbalance, kidney disease introduces a cocktail of other promoters: uremic toxins, chronic low-grade inflammation, and oxidative stress, all of which tip the scale further toward calcification.8PubMed Central. Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall In advanced kidney failure, inactive MGP levels in the blood predict how severe calcification will become, in both the intima and the media of the vessels.9Scientific Reports. Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease
The most extreme consequence in kidney patients is calciphylaxis, a rare and life-threatening condition in which tiny arterioles in the skin calcify and clot, producing excruciating wounds and tissue death. Risk factors that come up repeatedly include low albumin, elevated alkaline phosphatase, diabetes, higher body weight, female sex, and the use of vitamin K-blocking blood thinners.10PubMed Central. Calciphylaxis in chronic kidney disease: a systematic review of pathomechanisms and risk factors for calcific uremic arteriolopathy Infections from these wounds make calciphylaxis lethal in a significant number of cases.11Journal of Nephrology. Calciphylaxis: a still unmet challenge
What Calcified Arteries Do to Blood Pressure and Organs
Healthy arteries are elastic. They expand with each heartbeat and recoil between beats, smoothing the pulse of blood flow so that organs receive steady perfusion. Calcified arteries lose that elasticity. The result is isolated systolic hypertension, where the top blood pressure number climbs while the bottom number stays normal or even drops. This pattern is extremely common in older adults and is recognized as a major consequence of medial arterial calcification.12PubMed. Vascular calcification and hypertension: cause and effect
The heart pays a steep price. Stiffened arteries increase the workload on the left ventricle with every beat. In hemodialysis patients, calcification has been identified as the single most important contributor to left ventricular thickening, a structural change that raises the risk of heart failure.13Hypertension Research. Left Ventricular Hypertrophy Is Associated with Arterial Stiffness and Vascular Calcification in Hemodialysis Patients
In the legs, the consequences are equally serious. Medial calcification in peripheral arteries correlates independently with higher rates of amputation and death among patients with peripheral artery disease.14PubMed Central. Medial artery calcification in peripheral artery disease Calcification was an independent predictor of worsening limb ischemia even after researchers accounted for the extent of vessel blockage and standard cardiovascular risk factors like smoking and diabetes duration.15PubMed Central. Association of arterial calcification with chronic limb ischemia in patients with peripheral artery disease An added problem: medial calcification was historically thought to avoid narrowing the vessel lumen, but accumulating evidence shows that heavy medial deposits can deform the artery wall inward, cause tissue overgrowth beneath the lining, and ultimately reduce blood flow after all.16Frontiers in Cardiovascular Medicine. Lower limb arterial calcification and its clinical relevance with peripheral arterial disease
Measuring Calcification and Predicting Risk
The most established way to quantify arterial calcification is the coronary artery calcium (CAC) score, obtained from a low-dose CT scan of the heart. A CAC score of zero is reassuring; higher numbers indicate increasing plaque burden. Across multiple population-based studies with follow-up periods of up to fifteen years, the CAC score has proven to be a consistent, reproducible predictor of heart attacks, strokes, and cardiovascular death. It is especially useful in people without symptoms, helping to decide whether preventive therapies like statins are worthwhile.17PubMed Central. Coronary Calcium Score and Cardiovascular Risk
There are limits, though. CAC scoring detects established, macroscopic calcium. It cannot distinguish between stable, dense calcification and the early, active microcalcification that may signal a vulnerable plaque about to rupture. A newer imaging approach uses a radioactive tracer, ¹⁸F-sodium fluoride, combined with PET scanning. The tracer binds selectively to tiny, actively forming calcium crystals within plaques, allowing doctors to visualize calcification that is happening right now rather than calcium that settled years ago.18Nature Communications. Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography In longitudinal studies, higher tracer uptake predicted the future appearance of new coronary calcium deposits on CT, suggesting the technique can catch calcification at a stage when intervention might still slow it down.19PubMed. (18)F-Sodium Fluoride Positron Emission Tomography Activity Predicts the Development of New Coronary Artery Calcifications
An unexpected screening opportunity is emerging in women. Calcification in the breast arteries, routinely visible on mammograms, has been linked to cardiovascular outcomes. In postmenopausal women, the presence of breast arterial calcification was associated with roughly a fifty percent higher risk of atherosclerotic cardiovascular events, even after adjusting for traditional risk factors.20PubMed Central. Breast Arterial Calcification: a Novel Cardiovascular Risk Enhancer Among Postmenopausal Women Because millions of mammograms are performed each year, automated AI-based measurement of breast arterial calcification could offer a low-cost addition to cardiovascular risk assessment without requiring any extra tests.21PubMed Central. Automated Breast Arterial Calcification Score Is Associated With Cardiovascular Outcomes and Mortality
The Statin Paradox
If you have been told your CAC score went up after starting a statin, you are not alone, and the explanation is counterintuitive. Statins reduce cardiovascular events by stabilizing plaques and lowering cholesterol, yet multiple studies show they simultaneously increase the amount of calcium visible on CT scans. The mechanism appears to involve two things: statins promote the healing of inflamed plaques by shifting immune cells toward an anti-inflammatory state, and this healing process itself drives mineralization. Statins also activate certain bone-forming signaling pathways in smooth muscle cells, further encouraging calcium deposition within the plaque.22PubMed Central. The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review
This is where the paradox resolves. Dense, stable calcium within a plaque may actually be a sign of healing rather than danger. A heavily calcified plaque with a thick cap is far less likely to rupture and cause a heart attack than a soft, lipid-rich plaque with scattered microcalcification. One analysis found that statin-driven increases in HDL cholesterol partially offset the statistical link between statin use and higher CAC scores, suggesting the net cardiovascular effect remains protective even as the calcium number climbs.23PLOS ONE. Investigating potential mediator between statin and coronary artery calcification The practical takeaway: a rising CAC score during statin therapy does not mean the drug is failing. Serial CAC scoring to monitor statin effectiveness can be misleading.
Warfarin, Vitamin K, and a Preventable Cause
Warfarin, one of the most widely prescribed blood thinners, works by blocking vitamin K recycling in the liver to reduce blood clotting. The problem is that the same vitamin K recycling pathway operates in artery walls, where it activates MGP, the natural calcification inhibitor. When warfarin shuts that pathway down, MGP remains inactive and unable to do its protective job. In animal models, warfarin markedly increased calcium concentrations across multiple arteries, with some vessels showing calcium levels up to twenty-fold higher than controls.24Kidney International. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease In humans, warfarin use is an established risk factor for calciphylaxis and is consistently identified in clinical reviews of the condition.10PubMed Central. Calciphylaxis in chronic kidney disease: a systematic review of pathomechanisms and risk factors for calcific uremic arteriolopathy
The flip side is encouraging. In the same animal experiments, supplementing with high-dose vitamin K1 dramatically increased tissue vitamin K levels and blunted the development of calcification.24Kidney International. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease Vitamin K promotes MGP activation through a carboxylation step that is essential for the protein to bind and neutralize calcium crystals.25PubMed Central. The Inhibitory Roles of Vitamin K in Progression of Vascular Calcification This has raised an obvious clinical question: should patients on warfarin be switched to newer anticoagulants that do not interfere with vitamin K? Many nephrologists now lean in that direction for kidney patients, though the decision depends on the individual’s clotting risk. The MGP-vitamin K connection also underpins MGP and Gas-6, two vitamin K-dependent proteins critical for vascular protection, both of which lose function during warfarin use.26PubMed Central. Vitamin K-dependent proteins, warfarin, and vascular calcification
Treatment Options Under Investigation
No drug is approved to reverse established arterial calcification outright, but several are being tested to slow its progression. Sodium thiosulfate, an inorganic compound already used for cyanide poisoning and some skin conditions, has been the most studied candidate. In hemodialysis patients, intravenous sodium thiosulfate slowed the rise in coronary and iliac artery calcium scores compared to untreated controls, and it reduced the progression of arterial stiffness as measured by pulse wave velocity.27PubMed Central. Intravenous sodium thiosulphate for vascular calcification of hemodialysis patients—a systematic review and meta-analysis In animal studies, the compound prevented aortic calcification in uremic rats, likely by boosting calcium excretion through the urine.28PubMed. Sodium thiosulfate prevents vascular calcifications in uremic rats
The enthusiasm comes with important caveats. In a meta-analysis focused on calciphylaxis specifically, sodium thiosulfate did not produce statistically significant improvements in skin lesion healing or survival compared with other approaches.29JAMA Network Open. Intravenous Sodium Thiosulphate for Calciphylaxis of Chronic Kidney Disease: A Systematic Review and Meta-analysis The animal data also flagged a concern: thiosulfate weakened bones in treated rats, raising the possibility of trading one problem for another.28PubMed. Sodium thiosulfate prevents vascular calcifications in uremic rats
A newer agent, SNF472, takes a different tack. Rather than flushing calcium from the body, it binds directly to hydroxyapatite crystals and blocks further crystal growth. In the CALIPSO trial of hemodialysis patients, those receiving SNF472 saw their coronary calcium scores rise by roughly half as much as the placebo group over the trial period.30Kidney International Reports. Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis — Subgroup Analyses of the CALIPSO Trial The benefit was consistent across patient subgroups. Lab work confirmed the mechanism: SNF472 physically adsorbs onto the mineral surface and prevents additional crystallization.31PubMed Central. Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis
When calcification has already stiffened an artery to the point where a stent cannot be placed safely, procedural tools exist to physically break up the mineral. Intravascular lithotripsy uses sound waves delivered inside the artery through a catheter-mounted balloon, cracking the calcium so the vessel wall becomes compliant enough for a stent to expand properly.32PubMed. Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease The approach has been validated in both coronary and leg arteries, where it facilitates endovascular treatment in vessels that calcification would otherwise make untreatable.33PubMed. Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial
Calcium Supplements and the Question of Self-Inflicted Risk
Many older adults take calcium supplements for bone health, and a reasonable worry is whether those extra calcium ions end up in the wrong place. The concern is not hypothetical. Elevated calcium in the blood, even within the normal range, has been associated with more calcified coronary plaque, and lab studies show that high calcium concentrations directly push smooth muscle cells toward mineralization.34PubMed Central. Calcium Supplements and Risk of Cardiovascular Disease: A Meta-Analysis of Clinical Trials Healthy kidneys have a limited capacity to dump excess calcium, and that capacity shrinks with age and any degree of reduced kidney function.35PubMed Central. Risk of high dietary calcium for arterial calcification in older adults
The observational and trial evidence is mixed but leans cautious. Some studies of calcium supplementation have suggested cardiovascular harm, while others have not. The consensus position from cardiology reviews is that calcium intake should come primarily from food rather than pills, and that supplementation should be used only when dietary intake falls short of recommended levels.36PubMed. Vitamin D, Calcium Supplements, and Implications for Cardiovascular Health: JACC Focus Seminar The spike in blood calcium that follows swallowing a supplement tablet is much steeper than the gradual absorption from food, which may explain why pills carry a different risk profile than dietary calcium at similar total intakes.
Genetic Causes and the Gut Microbiome
Most arterial calcification develops over decades and reflects the cumulative burden of aging, metabolic disease, and lifestyle. But when severe calcification appears in young people, a hereditary disorder is often the explanation. A handful of rare single-gene conditions cause early-onset vascular calcification. These fall into categories based on what the faulty gene does: some disrupt the body’s production of pyrophosphate (a mineral inhibitor that prevents crystals from forming), others involve overactive inflammatory signaling, and one, Gaucher disease, involves lipid storage in cells.37PubMed. Hereditary Disorders of Cardiovascular Calcification One such condition, ACDC, results from mutations that impair an enzyme responsible for generating adenosine. Patients develop progressive calcification of leg arteries, sometimes requiring surgery for limb ischemia at a young age.38PubMed Central. Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC
On a completely different front, researchers are finding connections between the gut microbiome and arterial calcification. Short-chain fatty acids, particularly propionate, produced by intestinal bacteria during fiber digestion, correlated negatively with calcification scores in a clinical cohort. When propionate was given to animals with experimentally induced calcification, it reshaped the gut microbiome, strengthened the intestinal barrier, reduced systemic inflammation, and lessened vascular calcium deposits.39PubMed Central. Beneficial effect of the short-chain fatty acid propionate on vascular calcification through intestinal microbiota remodelling These findings are early-stage, but they suggest that diet quality, specifically fiber intake, may influence calcification through microbial metabolites in addition to its well-known effects on cholesterol and blood pressure.
Arterial Calcification in Ancient Humans
It would be comforting to blame modern diets and sedentary lifestyles for all arterial calcification, but the archaeological record complicates that story. CT scans of fifty-two ancient Egyptian mummies revealed identifiable cardiovascular structures in most, and nearly half of those had definite or probable atherosclerotic calcification. Calcium deposits were found in the aorta, coronary arteries, carotid arteries, and leg vessels.40PubMed. Atherosclerosis in ancient Egyptian mummies: the Horus study The mummies studied tended to come from higher social strata, which may reflect dietary factors unique to the ancient elite, but the finding still shows that arterial calcification long predates processed food, trans fats, and office chairs. It may be that vascular calcification is, to some extent, an inherent feature of arterial aging in humans, amplified but not created by modern risk factors. The practical implication is that prevention is about managing risk rather than expecting to eliminate calcification entirely.